Skip to main content
Review article

Interferons in cancer immunoediting: sculpting metastasis and immunotherapy response

Michelle von LocquenghienCancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, SpainCatalina RozalénCancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, SpainToni Celià-TerrassaCancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain
2021en
ABI

Abstract

Interferons (IFNs) are pleiotropic cytokines critical for regulation of epithelial cell functions and for immune system regulation. In cancer, IFNs contribute to tumor-intrinsic and -extrinsic mechanisms that determine the quality of antitumor immunity and response to immunotherapy. In this Review, we focus on the different types of tumor IFN sensitivity that determine dynamic tumor-immune interactions and their coevolution during cancer progression and metastasis. We extend the discussion to new evidence supporting immunotherapy-mediated immunoediting and the dual opposing roles of IFNs that lead to immune checkpoint blockade response or resistance. Understanding the intricate dynamic responses to IFN will lead to novel immunotherapeutic strategies to circumvent protumorigenic effects of IFN while exploiting IFN-mediated antitumor immunity.

Identifiers

Citations and references

Cited by 20 references